Evaluation of the Mechanism of Action of Platelet Rich Fibrin Matrix (PRFM) in Producing Skin Volume Augmentation
| Status: | Completed |
|---|---|
| Conditions: | Healthy Studies |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 25 - 75 |
| Updated: | 4/21/2016 |
| Start Date: | October 2009 |
| End Date: | July 2011 |
Autologous platelet rich fibrin matrix will release growth factors which could increase the
production of dermal proteins or affect the vascularity and status of neighboring tissues.
This study is designed to evaluate the histologic and biochemical effect of injection of
platelet rich fibrin matrix into the skin.
production of dermal proteins or affect the vascularity and status of neighboring tissues.
This study is designed to evaluate the histologic and biochemical effect of injection of
platelet rich fibrin matrix into the skin.
Subjects will be treated with platelet rich fibrin matrix into the skin of the inner aspect
of the upper arm. Injected areas will be monitored clinically and will also undergo biopsies
between 30 minutes and 12 weeks after treatment. Specimen of treated areas will undergo
histologic and biochemical analysis and comparison to standard laboratory control specimen
of untreated skin.
of the upper arm. Injected areas will be monitored clinically and will also undergo biopsies
between 30 minutes and 12 weeks after treatment. Specimen of treated areas will undergo
histologic and biochemical analysis and comparison to standard laboratory control specimen
of untreated skin.
Inclusion Criteria:
- 25 and 75 years of age
Exclusion Criteria:
- collagen vascular disorders
- autoimmune diseases
- signs or history of impaired wound healing
- shall not have had any infectious or inflammatory processes at the treatment sites
within the prior 6 months
We found this trial at
1
site
Click here to add this to my saved trials
